The Effectiveness of Health Management-Assisted Technology on Glycated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus: Meta-Analysis
AbstractBackground: Given the number of patients failing to achieve control of Diabetes Mellitus (DM), it causes an increase in the incidence of DM complications. Along with the rapid development of technology in this era, this study aimed to prove the effectiveness of technology-based health management compared to usual treatment for levels glycated hemoglobin (HbA1c) in type 2 diabetes mellitus patients.Subjects and Method: This was a meta-analysis using a randomized controlled trial. Articles were obtained from PubMed, Google Scholar, and ResearchGate databases. The articles used in this study were those published from 2012-2021. The search article was carried out by considering the eligibility of the criteria determined using the PICO model. Population: type 2 DM patients (HbA1c>7%), Intervention: health management-assisted technology, Comparison: usual care Outcome: HbA1c levels. There were 10 articles used with a sample size of 1693 people who were divided into two groups (845 people in the health management-assisted technology group and 848 people in the group usual care). Articles were analyzed using Review Manager 5.3 Application to determine the Standard Mean Difference (SMD) and heterogeneity of the study sample.Results: From 10 articles that were processed using RevMan 5.3, significant results were obtained, this is indicated by the overall effect (diamond) which does not touch the vertical line H0 (d= 0) and can also be seen from the 95% CI range of -0.62 to -0.13 which shows significant because it does not pass the number 0 (SMD= -0.37; 95% CI= -0.62 to -0.13; p= 0.003). The heterogeneity of the research data shows I2 = 82% so that the distribution of the data is very heterogeneous (random effects model).Conclusion: Using technology to help health management of patients with type 2 diabetes mellitus can reduce HbA1c levels compared to usual care.Keywords: Health management, technology, diabetes mellitus, HbA1cCorrespondence: Fajar Novianto. Center for Research and Development of Medicinal Plants and Traditional Medicine, National Institute of Health of Health, Jl. Raya Lawu No. 11 Karanganyar, Central Java. Email: firstname.lastname@example.org.Journal of Health Policy and Management (2021), 06(02): 81-93https://doi.org/10.26911/thejhpm.2021.06.02.01
Atmojo J, Sudaryanto W, Widiyanto A, Ernawati, Arradini D (2020). Telemedicine, cost effectiveness, and patients satisfaction: A systematic review. J Health Policy Manage. 5(2): 103-107. https://doi.org/10.26911/thejhpm.2020.05.02.02.
Brath H, Morak J, Kästenbauer T, Modre-Osprian R, Strohner-Kästenbauer H, Schwarz M, Kort W, et al. (2013). Mobile health (mHealth) based medi-cation adherence measurement - a pilot trial using electronic blisters in diabetes patients. British Journal of Clinical Pharmacology, 76(1): 47–55. https://doi.org/10.1111/bcp.12184
Changizi M, Kaveh MH (2017). Effective-ness of the mHealth technology in improvement of healthy behaviors in an elderly population-a systematic review. MHealth, 3(51). https://doi.org/10.21037/mhealth.2017.08.06
Crowley MJ, Edelman D, McAndrew AT, Kistler S, Danus S, Webb JA, Zanga J et al. (2016). Practical telemedicine for veterans with persistently poor diabetes control: A randomized pilot trial. Telemedicine and E-Health, 22(5): 376–384. https://doi.org/10.1089/tmj.2015.0145.
Fountoulakis S, Papanastasiou L, Gryparis A, Markou A, Piaditis G (2015). Im-pact and duration effect of telemoni-toring on HbA1c, BMI and cost in insulin-treated diabetes mellitus pati-ents with inadequate glycemic con-trol: A randomized controlled study. Hormones, 14(4): 632–643. https://doi.org/10.14310/horm.2002.1603.
Heisler M, Choi H, Palmisano G, Mase R, Richardson C, Fagerlin A, Montori VM et al. (2014). Comparison of com-munity health worker-led diabetes medication decision-making support for low-income Latino and African American adults with diabetes using e-Health tools versus print materials: A randomized controlled trial. Ann Intern Med, 161(100). S13 – S22. https://doi.org/doi:10.7326/M13-30-12.
Hsu WC, Lau KHK, Huang R, Ghiloni S, Le H, Gilroy S, Abrahamson M et al. (2016). Utilization of a cloud-based diabetes management program for insulin initiation and titration enables collaborative decision making between healthcare providers and patients. Diabetes Technology and Therapeutics. 18(2): 59–67. https://doi.org/10.1089/dia.2015.0160.
Kempf K, Altpeter B, Berger J, Reuß O, Fuchs M, Schneider M, Gärtner B, et al. (2017). Efficacy of the telemedical lifestyle intervention program TeLiPro in advanced stages of type 2 diabetes: A randomized controlled trial. Diabetes Care. 40(7): 863–871. https://doi.org/10.2337/dc17-0303.
Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V (2017). Improved medication adherence and frequency of blood glucose self-testing using an m-health platform versus usual care in a multisite randomized clinical trial among people with type 2 diabetes in India. Telemedicine Journal and E-Health: The Official Journal of the American Telemedicine Association. 23(9): 733–740. https://doi.org/10.-1089/tmj.2016.0265.
Klingeman H, Funnell M, Jhand A, Lath-kar-Pradhan S, Hodish I (2017). Type 2 diabetes specialty clinic model for the accountable care organization era. Journal of Diabetes and Its Compli-cations, 31(10): 1521–1526. https://-doi.org/10.1016/j.jdiacomp.2017.05.011.
Ministry of Health RI (2018). Infodatin cen-ter for data and information of the Ministry of Health of the Republic of Indonesia. World Diabetes Day. Ministry of Health of the Republic of Indonesia.
Murti B (2018). Epidemiological Research Principles and Methods. (V). Bintang Fajar Offsite Colomadu.
Nanditha A, Thomas H, Susairaj P, Srivani-chakorn W, Oliver N, Godsland IF, Majeed A, et al. (2020). Pragmatic and scalable strategies using cellular technology to promote sustainable lifestyle changes to prevent type 2 diabetes in India and UK. Diabetalogia, 63: 489–496. https://doi.org/10.1007/s00125-019-05061-y.
Nicolucci A, Cercone S, Chiriatti A, Muscas F, Gensini G, Fucito G, Gambini A, et al. (2015). A randomized trial on home telemonitoring for the manage-ment of metabolic and cardiovascular risk in patients with type 2 diabetes. Diabetes Technology and Therapeu-tics. 17(8): 563–570. https://doi.org/10.1089/dia.2014.0355.
Oktovin O, Unja EE, Rachman A (2018). Systematic review: Use of smartpho-nes for life style management programs for type 2 diabetes mellitus patients. JKSI. 3(2): 1–10. https://doi.org/10.51143/jksi.v3i2.102.
Ramadhan N, Marissa N (2015). Characte-ristics of type 2 diabetes mellitus patients based on HbA1c levels at the Jayabaru Community Health Center, Banda Aceh City. SEL. 2(2): 49–56.
Ocean WS (2020). Effectiveness of mobile health intervention on self-manage-ment and glycemic control in patients with type 2 diabetes mellitus: A systematic review. Forikes Journal of Sound Health Research. 4(11).
Tang P, Overhage JM, Chan AS, Brown NL, Aghighi B, Entwistle MP, Hui SL, et al. (2013). Online disease management of diabetes: engaging and motivating patients online with enhanced resources-diabetes (EMPOWER-D), a randomized controlled trial. Journal of the American Medical Informatics Association. 20(3): 526–524. https:-//doi.org/10.1136/amiajnl-2012-00-1263.
Tildesley HD, Wright AM, Chan JHM, Mazanderani AB, Ross SA, Tildesley HG, Lee AM, et al. (2013). A compari-son of internet monitoring with conti-nuous glucose monitoring in insulin-requiring type 2 diabetes mellitus. Canadian Journal of Diabetes. 37(5): 305–308. https://doi.org/10.1016/j.-jcjd.2013.05.006.
WHO (2019). Classification of diabetes mellitus. World Health Organization. https://www.who.int/publications/i/item/classification-of-diabetes-melli-tus.
Wild SH, Hanley J, Lewis SC, McKnight JA, McCloughan LB, Padfield PL, Parker R, et al. (2016). Supported telemoni-toring and glycemic control in people with type 2 diabetes: The telescot dia-betes pragmatic multicenter rando-mized controlled trial. https://doi.org/10.1371/journal.pmed.1002098.